United States signs about $1 bln order for GSK-Vir COVID-19 antibody drug
- United States
The United States has signed contracts worth roughly $1 billion to secure antibody-based COVID-19 treatment sotrovimab from GSK and Vir Biotechnology , the drugmakers said on Wednesday, with supply expected by mid-December.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- The United States